Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-285582
Filing Date
2020-11-04
Accepted
2020-11-04 16:17:25
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-3 d41514ds3.htm S-3 463797
2 EX-1.2 d41514dex12.htm EX-1.2 201717
3 EX-4.4 d41514dex44.htm EX-4.4 306982
4 EX-4.6 d41514dex46.htm EX-4.6 97612
5 EX-4.7 d41514dex47.htm EX-4.7 98993
6 EX-4.8 d41514dex48.htm EX-4.8 85205
7 EX-5.1 d41514dex51.htm EX-5.1 29164
8 EX-23.1 d41514dex231.htm EX-23.1 2245
9 GRAPHIC g41514dsp58.jpg GRAPHIC 3914
10 GRAPHIC g41514g1031084921394.jpg GRAPHIC 2981
11 GRAPHIC g41514g1031084921706.jpg GRAPHIC 2960
12 GRAPHIC g41514g1031084921878.jpg GRAPHIC 2859
13 GRAPHIC g41514g1031084922065.jpg GRAPHIC 1798
14 GRAPHIC g41514g1031084922299.jpg GRAPHIC 2969
  Complete submission text file 0001193125-20-285582.txt   1311790
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-249848 | Film No.: 201286924
SIC: 2834 Pharmaceutical Preparations